Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.28 USD | -0.52% | -4.21% | -21.09% |
01:41pm | Bristol-Myers Squibb Gains EU Approval for Opdivo Combination Therapy for Urothelial Cancer | MT |
01:26pm | Bristol Myers: new EC approval for Opdivo | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.09% | 82.08B | |
+38.59% | 727B | |
+29.90% | 592B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+12.81% | 238B | |
+6.96% | 204B | |
-5.73% | 203B | |
-1.70% | 160B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- UBS Adjusts Bristol-Myers Squibb Price Target to $77 From $75, Maintains Neutral Rating